Inventisbio Co., Ltd

This study is testing an investigational oral drug called D-2570 to see if it can clear skin lesions and improve quality of life for people with moderate to severe plaque psoriasis. It will enroll 390 participants who will be randomly assigned to receive either the active drug or…

This study is testing whether an experimental medication called D-2570 can help control symptoms of active psoriatic arthritis. Researchers will enroll 222 adults with the condition to compare different doses of the drug against a placebo over 12 weeks. The main goal is to see if…

This is an early, first-in-human study to check the safety of a new drug called D-2570. It will involve 36 healthy volunteers who will receive either the drug or a placebo (inactive pill) at different dose levels. The main goal is to see how safe the drug is and how the body abso…